Osteoarthritis of the Knee Clinical Trial
— EMBARKOfficial title:
Exploring Massage Benefits for Arthritis of the Knee
In 2004, we conducted a pilot randomized, wait list controlled, trial (RCT) of massage
therapy for OA of the knee in 68 subjects. That study, supported by CDC grant SIP-14-00,
revealed the potential efficacy of Swedish massage therapy in the treatment of OA of the
knee, with benefits of increased function and decreased pain persisting at least eight weeks
following treatment cessation. The results of that trial, the first RCT of massage for OA,
were published in the Archives of Internal Medicine in 2006 (See reference in More
Information section). This current project builds on the design and findings of the pilot
trial to determine the optimal dose and treatment regimen and provide longer term follow up.
This project is a dual-site, randomized, dose-ranging trial to compare four dose/regimens in
order to identify the optimal protocol for clinical practice.
The primary study hypothesis is that an eight (8) week course of Swedish massage therapy of
one of the four proposed doses (by frequency and duration of massage treatment session) will
be effective in reducing pain and improving function in patients with confirmed OA of the
knee.
Status | Completed |
Enrollment | 125 |
Est. completion date | August 2011 |
Est. primary completion date | July 2011 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 35 Years and older |
Eligibility |
Inclusion Criteria: - 35 years of age or greater. - Written confirmation of OA of the knee as provided by the participant's physician. - Radiographically-established OA of the knee. - Pre-randomization score of 40 to 90 on the Visual Analog Pain Scale (0-100 mm scale). - Patients with bilateral knee involvement will have the more severely affected knee designated as the study knee. - American College of Rheumatology defined OA of the knee: 1. Knee pain 2. Satisfaction of at least five of the following nine criteria: 1. Age greater than 50 years 2. Stiffness < 30 minutes 3. Crepitus 4. Bony tenderness 5. Bony enlargement 6. No palpable warmth 7. ESR < 40 mm/hr 8. Rheumatoid Factor (RF) < 1:40 Exclusion Criteria: (no exclusion criterion may be present) - Presence of rheumatoid arthritis, fibromyalgia, recurrent or active pseudo gout. - Presence of cancer or other serious medical conditions. - Signs or history of kidney or liver failure. - Presence of asthma requiring the use of corticosteroid treatment. - Use of oral corticosteroids within the past four weeks. - Use of intra-articular knee depo-corticosteroids with the past three months. - Use of intra-articular hyaluronate with the past six months. - Arthroscopic surgery of the knee within the past year. - Significant injury to the knee within the past six months. - Presence of a rash or open wound over the knee. - Unable to satisfy the treatment and follow-up requirements. - Unable to provide written informed consent. - Currently receiving massage therapy on a regular basis (at least twice a month). - Knee replacement of study knee (ok if the knee not being studied has been replaced). |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United States | Yale-Griffin Prevention Research Center/Griffin Hospital | Derby | Connecticut |
United States | Siegler Center for Integrative Medicine - Saint Barnabas Ambulatory Care Center | Livingston | New Jersey |
Lead Sponsor | Collaborator |
---|---|
University of Medicine and Dentistry of New Jersey | Yale University |
United States,
Perlman AI, Sabina A, Williams AL, Njike VY, Katz DL. Massage therapy for osteoarthritis of the knee: a randomized controlled trial. Arch Intern Med. 2006 Dec 11-25;166(22):2533-8. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Improvement in WOMAC (Western Ontario Multipurpose Arthritis Centers) Knee and Hip Osteoarthritis Index | Six (6) months | No | |
Secondary | Safety | Six (6) months | Yes | |
Secondary | Improvement in range of motion as measured by a goniometer. | six (6) months | No | |
Secondary | Improvement in physical function as measured by time in seconds to walk fifty (50) feet on a level straight surface. | six (6) months | No | |
Secondary | Reduction in pain as measured by the Visual Analog Scale (VAS) for pain. | Six (6) months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03277066 -
A 4-week Study to Evaluate the Efficacy and Safety of HP-5000 in Subjects With Knee Osteoarthritis
|
Phase 2 | |
Recruiting |
NCT03090698 -
Outcomes of Injections in Patients Waiting for Total Knee Replacement
|
Phase 4 | |
Completed |
NCT02556710 -
A Study to Evaluate the Efficacy & Safety of an Intra-Articular Ampion Injection for Pain of Osteoarthritis of the Knee
|
Phase 3 | |
Completed |
NCT02242435 -
A Multiple Injection Study Evaluating Safety and Efficacy of Ampion in Osteoarthritis
|
Phase 3 | |
Withdrawn |
NCT02237846 -
Clinical Study of Umbilical Cord Tissue Mesenchymal Stem Cells (UC-MSC) for Treatment of Osteoarthritis
|
Phase 1/Phase 2 | |
Completed |
NCT01849445 -
Targeted Rehabilitation to Improve Outcome After Knee Replacement- A Physiotherapy Study
|
N/A | |
Completed |
NCT02096393 -
Patient Specific Instrumentation in TKR
|
N/A | |
Completed |
NCT01704157 -
A Prospective Study Evaluating the Treatment of Knee Osteoarthritis With the Cryo-Touch III Device
|
N/A | |
Active, not recruiting |
NCT01374230 -
Long-Term Multicenter Evaluation of the E1® Tibial Bearing
|
N/A | |
Not yet recruiting |
NCT01270412 -
Platelet Rich Plasma (PRP) as a Treatment for Knee Osteoarthritis PRP as a Treatment for Knee Osteoarthritis
|
Phase 2/Phase 3 | |
Completed |
NCT01410409 -
Structured Treatment of Osteoarthritis of the Knee With or Without Total Knee Replacement
|
N/A | |
Completed |
NCT02156440 -
Cross-over Study of the Efficacy and Safety of SierraSil Joint Formula 14 in Osteoarthritis of the Knee
|
Phase 2 | |
Completed |
NCT01207115 -
A Study of ABT-652 in Adults With Osteoarthritis Pain of the Knee
|
Phase 2 | |
Completed |
NCT01331278 -
A Comparative Study of Knee Systems
|
Phase 4 | |
Completed |
NCT00988091 -
Investigation of 1.2% Sodium Hyaluronate for Treatment of Painful Chronic Osteoarthritis of the Knee
|
Phase 3 | |
Completed |
NCT00531427 -
Buprenorphine Transdermal System (BTDS) in Subjects w/Mod-sev Osteoarthritis (OA) Chronic Pain of Knee
|
Phase 3 | |
Completed |
NCT00792727 -
HKT-500 in Adult Patients With Osteoarthritis (OA) Knee Pain
|
Phase 3 | |
Completed |
NCT00449696 -
Gel-200 Versus Placebo in Osteoarthritis of the Knee
|
Phase 3 | |
Completed |
NCT04145011 -
Coolief Cooled Radiofrequency vs. Conventional Radiofrequency to Manage OA Knee Pain
|
N/A | |
Completed |
NCT01430559 -
Effect Of Meloxicam Versus Placebo In Mainland Chinese Patients With Osteoarthritis Of The Knee
|
N/A |